MedTrace Logo

Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer

NCT01419210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2015-09-24

No results posted yet for this study

Summary

The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with ovarian cancer. Some of the alternative medicines include non-traditional drug and herbal therapies along with dietary and nutritional strategies. Only a few of these alternative medicines have been tested with women with ovarian cancer.

Conditions

Interventions

OTHER

Pre-study Questionnaire

Assess the interest level for various CAM topics through feedback received from the study participants

OTHER

Educational Presentations

Attend a two-hour presentation each week for four weeks

OTHER

CAM Therapies

Integrate the CAM topics of highest interest into participant's regular care

OTHER

Post-study Questionnaire

Examine the data to see if it supports recommending a larger, multi-site, integrative CAM program for other women with ovarian cancer

Sponsors & Collaborators

  • University of South Florida

    collaborator OTHER

  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Robert Wenham, M.D. · H. Lee Moffitt Cancer Center and Research Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2014-04-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419210 on ClinicalTrials.gov